Health Care·Health Care Services·$10.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.64 | N/A | -33.12% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.64 | N/A | -33.12% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concern over current market conditions. They emphasized a commitment to improving operational efficiency despite the disappointing EPS.
Management acknowledged the challenges faced in the quarter.
There were no specific updates on future guidance.
The focus remains on operational efficiency and patient care.
DaVita's earnings report indicates a significant miss on EPS, which may raise concerns among investors about the company's performance. The stock reacted negatively, dropping 0.39%, reflecting investor disappointment. The lack of revenue figures and guidance adds uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ROCKET COMPANIES CLA A
Nov 4, 2013